Recently, overexpression of AP-2α in pancreatic cancer cells was shown to reduce tumor growth through an altered expression pattern of cell cycle-controlling factors such as CDK-4, CDK-6, cyclin-G1, p27kip1 and p57kip2[22]. The gene discussed is CDKN1B; the disease is pancreatic neoplasm.